Global and United States Ulcerative Colitis Medicine Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Ulcerative Colitis Medicine Market
This report focuses on global and United States Ulcerative Colitis Medicine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Ulcerative Colitis Medicine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 5-Aminosalicylic Acid accounting for % of the Ulcerative Colitis Medicine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Ulcerative Proctitis was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Ulcerative Colitis Medicine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Ulcerative Colitis Medicine Scope and Market Size
Ulcerative Colitis Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ulcerative Colitis Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Ulcerative Colitis Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    5-Aminosalicylic Acid
    Corticosteroids
    Immunomodulator Drugs
    Biologics

Segment by Application
    Ulcerative Proctitis
    Proctosigmoiditis
    Left-Sided Colitis
    Pancolitis
    Acute Severe Ulcerative Colitis

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Sumitomo
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson and Johnson
    GSK
    AstraZeneca
    Cipla
    Sun Pharm
    Allergan
    Teva Pharmaceutical

 1 Study Coverage
    1.1 Ulcerative Colitis Medicine Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Ulcerative Colitis Medicine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Ulcerative Colitis Medicine Market Size for the Year 2017-2028
        1.2.2 Global Ulcerative Colitis Medicine Market Size for the Year 2017-2028
    1.3 Ulcerative Colitis Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Ulcerative Colitis Medicine in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Ulcerative Colitis Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Ulcerative Colitis Medicine Market Dynamics
        1.4.1 Ulcerative Colitis Medicine Industry Trends
        1.4.2 Ulcerative Colitis Medicine Market Drivers
        1.4.3 Ulcerative Colitis Medicine Market Challenges
        1.4.4 Ulcerative Colitis Medicine Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Ulcerative Colitis Medicine by Type
    2.1 Ulcerative Colitis Medicine Market Segment by Type
        2.1.1 5-Aminosalicylic Acid
        2.1.2 Corticosteroids
        2.1.3 Immunomodulator Drugs
        2.1.4 Biologics
    2.2 Global Ulcerative Colitis Medicine Market Size by Type (2017, 2022 & 2028)
    2.3 Global Ulcerative Colitis Medicine Market Size by Type (2017-2028)
    2.4 United States Ulcerative Colitis Medicine Market Size by Type (2017, 2022 & 2028)
    2.5 United States Ulcerative Colitis Medicine Market Size by Type (2017-2028)

 3 Ulcerative Colitis Medicine by Application
    3.1 Ulcerative Colitis Medicine Market Segment by Application
        3.1.1 Ulcerative Proctitis
        3.1.2 Proctosigmoiditis
        3.1.3 Left-Sided Colitis
        3.1.4 Pancolitis
        3.1.5 Acute Severe Ulcerative Colitis
    3.2 Global Ulcerative Colitis Medicine Market Size by Application (2017, 2022 & 2028)
    3.3 Global Ulcerative Colitis Medicine Market Size by Application (2017-2028)
    3.4 United States Ulcerative Colitis Medicine Market Size by Application (2017, 2022 & 2028)
    3.5 United States Ulcerative Colitis Medicine Market Size by Application (2017-2028)

 4 Global Ulcerative Colitis Medicine Competitor Landscape by Company
    4.1 Global Ulcerative Colitis Medicine Market Size by Company
        4.1.1 Top Global Ulcerative Colitis Medicine Companies Ranked by Revenue (2021)
        4.1.2 Global Ulcerative Colitis Medicine Revenue by Player (2017-2022)
    4.2 Global Ulcerative Colitis Medicine Concentration Ratio (CR)
        4.2.1 Ulcerative Colitis Medicine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Ulcerative Colitis Medicine in 2021
        4.2.3 Global Ulcerative Colitis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Ulcerative Colitis Medicine Headquarters, Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Ulcerative Colitis Medicine Headquarters and Area Served
        4.3.2 Global Ulcerative Colitis Medicine Companies Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Ulcerative Colitis Medicine Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Ulcerative Colitis Medicine Market Size by Company
        4.5.1 Top Ulcerative Colitis Medicine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Ulcerative Colitis Medicine Revenue by Players (2020, 2021 & 2022)

 5 Global Ulcerative Colitis Medicine Market Size by Region
    5.1 Global Ulcerative Colitis Medicine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Ulcerative Colitis Medicine Market Size by Region (2017-2028)
        5.2.1 Global Ulcerative Colitis Medicine Market Size by Region: 2017-2022
        5.2.2 Global Ulcerative Colitis Medicine Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Ulcerative Colitis Medicine Market Size YoY Growth 2017-2028
        6.1.2 North America Ulcerative Colitis Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Ulcerative Colitis Medicine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Ulcerative Colitis Medicine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Ulcerative Colitis Medicine Market Size YoY Growth 2017-2028
        6.3.2 Europe Ulcerative Colitis Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Ulcerative Colitis Medicine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Ulcerative Colitis Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Ulcerative Colitis Medicine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Ulcerative Colitis Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Sumitomo
        7.1.1 Sumitomo Company Details
        7.1.2 Sumitomo Business Overview
        7.1.3 Sumitomo Ulcerative Colitis Medicine Introduction
        7.1.4 Sumitomo Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.1.5 Sumitomo Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Ulcerative Colitis Medicine Introduction
        7.2.4 Pfizer Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Ulcerative Colitis Medicine Introduction
        7.3.4 Novartis Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Ulcerative Colitis Medicine Introduction
        7.4.4 Merck Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 Sanofi
        7.5.1 Sanofi Company Details
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Ulcerative Colitis Medicine Introduction
        7.5.4 Sanofi Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.5.5 Sanofi Recent Development
    7.6 Johnson and Johnson
        7.6.1 Johnson and Johnson Company Details
        7.6.2 Johnson and Johnson Business Overview
        7.6.3 Johnson and Johnson Ulcerative Colitis Medicine Introduction
        7.6.4 Johnson and Johnson Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.6.5 Johnson and Johnson Recent Development
    7.7 GSK
        7.7.1 GSK Company Details
        7.7.2 GSK Business Overview
        7.7.3 GSK Ulcerative Colitis Medicine Introduction
        7.7.4 GSK Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.7.5 GSK Recent Development
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Details
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Ulcerative Colitis Medicine Introduction
        7.8.4 AstraZeneca Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.8.5 AstraZeneca Recent Development
    7.9 Cipla
        7.9.1 Cipla Company Details
        7.9.2 Cipla Business Overview
        7.9.3 Cipla Ulcerative Colitis Medicine Introduction
        7.9.4 Cipla Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.9.5 Cipla Recent Development
    7.10 Sun Pharm
        7.10.1 Sun Pharm Company Details
        7.10.2 Sun Pharm Business Overview
        7.10.3 Sun Pharm Ulcerative Colitis Medicine Introduction
        7.10.4 Sun Pharm Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.10.5 Sun Pharm Recent Development
    7.11 Allergan
        7.11.1 Allergan Company Details
        7.11.2 Allergan Business Overview
        7.11.3 Allergan Ulcerative Colitis Medicine Introduction
        7.11.4 Allergan Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.11.5 Allergan Recent Development
    7.12 Teva Pharmaceutical
        7.12.1 Teva Pharmaceutical Company Details
        7.12.2 Teva Pharmaceutical Business Overview
        7.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Introduction
        7.12.4 Teva Pharmaceutical Revenue in Ulcerative Colitis Medicine Business (2017-2022)
        7.12.5 Teva Pharmaceutical Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Ulcerative Colitis Medicine Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Ulcerative Colitis Medicine Market Trends
    Table 3. Ulcerative Colitis Medicine Market Drivers
    Table 4. Ulcerative Colitis Medicine Market Challenges
    Table 5. Ulcerative Colitis Medicine Market Restraints
    Table 6. Global Ulcerative Colitis Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ulcerative Colitis Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ulcerative Colitis Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ulcerative Colitis Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ulcerative Colitis Medicine Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ulcerative Colitis Medicine Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Ulcerative Colitis Medicine Revenue Share by Player, 2017-2022
    Table 13. Global Ulcerative Colitis Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ulcerative Colitis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis Medicine as of 2021)
    Table 15. Top Players of Ulcerative Colitis Medicine in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Ulcerative Colitis Medicine Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Ulcerative Colitis Medicine Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Ulcerative Colitis Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Ulcerative Colitis Medicine Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Ulcerative Colitis Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Ulcerative Colitis Medicine Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Ulcerative Colitis Medicine Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Ulcerative Colitis Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Ulcerative Colitis Medicine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Ulcerative Colitis Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Ulcerative Colitis Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Ulcerative Colitis Medicine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Sumitomo Company Details
    Table 31. Sumitomo Business Overview
    Table 32. Sumitomo Ulcerative Colitis Medicine Product
    Table 33. Sumitomo Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 34. Sumitomo Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Ulcerative Colitis Medicine Product
    Table 38. Pfizer Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Ulcerative Colitis Medicine Product
    Table 43. Novartis Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Ulcerative Colitis Medicine Product
    Table 48. Merck Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. Sanofi Company Details
    Table 51. Sanofi Business Overview
    Table 52. Sanofi Ulcerative Colitis Medicine Product
    Table 53. Sanofi Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 54. Sanofi Recent Development
    Table 55. Johnson and Johnson Company Details
    Table 56. Johnson and Johnson Business Overview
    Table 57. Johnson and Johnson Ulcerative Colitis Medicine Product
    Table 58. Johnson and Johnson Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 59. Johnson and Johnson Recent Development
    Table 60. GSK Company Details
    Table 61. GSK Business Overview
    Table 62. GSK Ulcerative Colitis Medicine Product
    Table 63. GSK Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 64. GSK Recent Development
    Table 65. AstraZeneca Company Details
    Table 66. AstraZeneca Business Overview
    Table 67. AstraZeneca Ulcerative Colitis Medicine Product
    Table 68. AstraZeneca Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 69. AstraZeneca Recent Development
    Table 70. Cipla Company Details
    Table 71. Cipla Business Overview
    Table 72. Cipla Ulcerative Colitis Medicine Product
    Table 73. Cipla Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 74. Cipla Recent Development
    Table 75. Sun Pharm Company Details
    Table 76. Sun Pharm Business Overview
    Table 77. Sun Pharm Ulcerative Colitis Medicine Product
    Table 78. Sun Pharm Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 79. Sun Pharm Recent Development
    Table 80. Allergan Company Details
    Table 81. Allergan Business Overview
    Table 82. Allergan Ulcerative Colitis Medicine Product
    Table 83. Allergan Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 84. Allergan Recent Development
    Table 85. Teva Pharmaceutical Company Details
    Table 86. Teva Pharmaceutical Business Overview
    Table 87. Teva Pharmaceutical Ulcerative Colitis Medicine Product
    Table 88. Teva Pharmaceutical Revenue in Ulcerative Colitis Medicine Business (2017-2022) & (US$ Million)
    Table 89. Teva Pharmaceutical Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ulcerative Colitis Medicine Product Picture
    Figure 2. Global Ulcerative Colitis Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ulcerative Colitis Medicine Market Size 2017-2028 (US$ Million)
    Figure 4. United States Ulcerative Colitis Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Ulcerative Colitis Medicine Market Size 2017-2028 (US$ Million)
    Figure 6. United States Ulcerative Colitis Medicine Market Share in Global 2017-2028
    Figure 7. Ulcerative Colitis Medicine Report Years Considered
    Figure 8. Product Picture of 5-Aminosalicylic Acid
    Figure 9. Product Picture of Corticosteroids
    Figure 10. Product Picture of Immunomodulator Drugs
    Figure 11. Product Picture of Biologics
    Figure 12. Global Ulcerative Colitis Medicine Market Share by Type in 2022 & 2028
    Figure 13. Global Ulcerative Colitis Medicine Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Ulcerative Colitis Medicine Market Share by Type (2017-2028)
    Figure 15. United States Ulcerative Colitis Medicine Market Share by Type in 2022 & 2028
    Figure 16. United States Ulcerative Colitis Medicine Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Ulcerative Colitis Medicine Market Share by Type (2017-2028)
    Figure 18. Product Picture of Ulcerative Proctitis
    Figure 19. Product Picture of Proctosigmoiditis
    Figure 20. Product Picture of Left-Sided Colitis
    Figure 21. Product Picture of Pancolitis
    Figure 22. Product Picture of Acute Severe Ulcerative Colitis
    Figure 23. Global Ulcerative Colitis Medicine Market Share by Application in 2022 & 2028
    Figure 24. Global Ulcerative Colitis Medicine Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Ulcerative Colitis Medicine Market Share by Application (2017-2028)
    Figure 26. United States Ulcerative Colitis Medicine Market Share by Application in 2022 & 2028
    Figure 27. United States Ulcerative Colitis Medicine Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Ulcerative Colitis Medicine Market Share by Application (2017-2028)
    Figure 29. North America Ulcerative Colitis Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. United States Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Ulcerative Colitis Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Ulcerative Colitis Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. China Taiwan Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Ulcerative Colitis Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Ulcerative Colitis Medicine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Ulcerative Colitis Medicine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Sumitomo Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 61. Johnson and Johnson Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 62. GSK Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 63. AstraZeneca Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 64. Cipla Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 65. Sun Pharm Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 66. Allergan Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 67. Teva Pharmaceutical Revenue Growth Rate in Ulcerative Colitis Medicine Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Market Analysis and Insights: Global and United States Ulcerative Colitis Medicine Market
This report focuses on global and United States Ulcerative Colitis Medicine market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Ulcerative Colitis Medicine market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 5-Aminosalicylic Acid accounting for % of the Ulcerative Colitis Medicine global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Ulcerative Proctitis was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Ulcerative Colitis Medicine market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Ulcerative Colitis Medicine Scope and Market Size
Ulcerative Colitis Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ulcerative Colitis Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Ulcerative Colitis Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    5-Aminosalicylic Acid
    Corticosteroids
    Immunomodulator Drugs
    Biologics

Segment by Application
    Ulcerative Proctitis
    Proctosigmoiditis
    Left-Sided Colitis
    Pancolitis
    Acute Severe Ulcerative Colitis

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Sumitomo
    Pfizer
    Novartis
    Merck
    Sanofi
    Johnson and Johnson
    GSK
    AstraZeneca
    Cipla
    Sun Pharm
    Allergan
    Teva Pharmaceutical